Loading interface...

Benitowa-TM Tablet

Manufactured byAKUMENTIS HEALTHCARE LTD
ContainsBenidipine (4 mg) + Telmisartan (40 mg)
Description

Benitowa-TM Tablet is a combination medicine which may be used for the treatment of high blood pressure (hypertension). Patients are advised to maintain a strict exercise and diet regimen along with this medicine to get the best possible effect. This medicine is not recommended for use in patients less than 18 years of age.

How will this medicine affect me?

Consult top doctors online and get an answer now
Chat now
Chat now

Looking for a doctor?

Book an appointment with the top doctors near you
Book now
Book now

Side effects

Major & minor side effects for Benitowa-TM Tablet

  • Headache
  • Dizziness
  • Constipation
  • Skin rash
  • Decreased blood pressure
  • Lightheadedness
  • Palpitations
  • Edema
  • Changes in vision
  • Increased heartbeat
  • Difficult or painful urination
  • Abdominal pain
  • Diarrhea
  • Muscle pain
  • Weakness
  • Fever

Uses of Benitowa-TM Tablet

What is it prescribed for?

  • Hypertension (increased blood pressure)
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of this medicine can be observed within 1-2 hours of administration of the dose.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of side effects such as dizziness, lightheadedness, and fainting. It is advised that you do not perform any activities that require high mental alertness such as driving a vehicle or operating machinery if you consume alcohol during treatment with this medicine.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the drug based on your clinical condition.

Allergy

This medicine is not recommended for use in patients with a known allergy to benidipine, telmisartan, other angiotensin receptor blockers, or any other inactive ingredients present in the formulation.

Aliskiren

Coadministration of aliskiren and this combination medicine is not recommended due to the increased risk of serious adverse effects. This risk is especially higher in the elderly population and in patients with diabetes and kidney diseases.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the drug based on your clinical condition.
General warnings

Liver Disease

This medicine should be used with caution in patients with liver diseases due to the increased risk of adverse effects. Close monitoring of liver function tests, appropriate dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition.

Driving or Operating machinery

Use of this medicine may cause symptoms such as blurred vision, lightheadedness, dizziness, etc. in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.

Use in Elderly

This medicine should be used with caution in elderly patients due to the increased risk of very low blood pressure levels. Regular monitoring of blood pressure levels is necessary while using this medicine. Therapy should be initiated at low doses and the dose may be increased based on the clinical condition and therapeutic response.

Use in children

This medicine is not recommended for use in patients less than 18 years of age since the safety and efficacy of use are not clinically established.

Hyperkalemia

Use of this medicine may increase the potassium levels in the blood (hyperkalemia). This may cause serious side effects such as fatal cardiac rhythm irregularities. It is advised to avoid potassium-rich foods (potatoes, bananas) and other medicines that may increase potassium levels (potassium-sparing diuretics and potassium supplements) during treatment with this medicine.

Missed Dose

Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of side effects such as dizziness, lightheadedness, and fainting. It is advised that you do not perform any activities that require high mental alertness such as driving a vehicle or operating machinery if you consume alcohol during treatment with this medicine.
Interaction with Medicine

Antihypertensives

Aliskiren

Captopril

Insulin

Itraconazole

Cimetidine

Rifampicin

Disease interactions

Hypotension

This medicine is not recommended for use in patients suffering from low blood pressure levels (hypotension) since it may further lower the blood pressure, causing severe adverse effects. Replacement with a suitable alternative should be considered based on the clinical condition.

Liver Disease

This medicine should be used with extreme caution in patients with liver diseases due to the increased risk of severe adverse effects. Regular monitoring of liver function tests is required while taking this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be necessary in some cases based on the clinical condition.

Congestive heart failure

This medicine should be used with caution in patients with congestive heart failure since it may worsen the patient's condition. Close monitoring of blood pressure, electrolytes level, and heart function are recommended for such patients. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.
Food interactions
Consumption of grapefruit juice is not recommended during therapy with this medicine due to the increased risk of severe side effects. Symptoms like dizziness, headache, swelling of the hands and feet, etc. may be experienced if grapefruit juice is consumed during treatment with this medicine.
Lab interactions
Information not available.
Take this medicine exactly as advised by your doctor. It can be taken with or without food. Do not take in larger amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

May cause sleepiness

How it works
Benidipine and Telmisartan relax the blood vessels and promote the smooth flow of blood. Their combination is thus effective in reducing the blood pressure.
Legal Status

Unknown

Unknown

Unknown

Unknown

Classification

Category

Calcium channel blocking agents, Angiotensin receptor blockers

Schedule

Schedule H

Benidipine - DrugBank [Internet]. Drugbank.ca. 2018 [cited 7 September 2018]. Available from:

https://www.drugbank.ca/drugs/DB09231

[Internet]. Ohara-ch.co.jp. 2018 [cited 7 September 2018]. Available from:

https://www.ohara-ch.co.jp/appendix/pdf/inc03/benidipineHydrochloride8T-SIE.pdf

Telmisartan: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2017 [cited 1 March 2017]. Available from:

https://medlineplus.gov/druginfo/meds/a601249.html

[Internet]. 2017 [cited 1 March 2017]. Available from:

https://www.medicines.org.uk/emc/medicine/27835

DailyMed - Telmisartan tablet [Internet]. Dailymed.nlm.nih.gov. 2017 [cited 1 March 2017]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e1a907a7-fad9-a860-8639-4c6136c85734
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 15 Jul 2019

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.